Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q2 2026 Earnings

5MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.84

-0.61

-0.38

-0.15

Details

Expected EPS

-0.665631

Actual EPS

-0.74

Surprise EPS

-0.07

Surprise Percent

+11.17%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.74 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.